Prednisolone Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Cataract Surgery
Conditions:   Corneal Edema;   Corneal Defect;   Anterior Chamber Inflammation;   Ocular Pain;   Corneal Staining;   Visual Outcome;   CME - Cystoid Macular Edema Interventions:   Drug: Dextenza 0.4Mg Ophthalmic Insert;   Drug: Prednisolone Phosphate 1%/Moxifloxacin 0.5%/Bromfenac 0.075% compound Sponsor:   Nicole Fram M.D. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 23, 2022 Category: Research Source Type: clinical trials

An RCT of Mycophenolate Mofetil (MMF) in Fibrotic Hypersensitivity Pneumonitis
Condition:   Hypersensitivity Pneumonitis Interventions:   Drug: Mycophenolate Mofetil plus prednisolone;   Drug: Prednisolone Sponsor:   Postgraduate Institute of Medical Education and Research Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 23, 2022 Category: Research Source Type: clinical trials

Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Cataract Surgery
Conditions:   Corneal Edema;   Corneal Defect;   Anterior Chamber Inflammation;   Ocular Pain;   Corneal Staining;   Visual Outcome;   CME - Cystoid Macular Edema Interventions:   Drug: Dextenza 0.4Mg Ophthalmic Insert;   Drug: Prednisolone Phosphate 1%/Moxifloxacin 0.5%/Bromfenac 0.075% compound Sponsor:   Nicole Fram M.D. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 23, 2022 Category: Research Source Type: clinical trials

An RCT of Mycophenolate Mofetil (MMF) in Fibrotic Hypersensitivity Pneumonitis
Condition:   Hypersensitivity Pneumonitis Interventions:   Drug: Mycophenolate Mofetil plus prednisolone;   Drug: Prednisolone Sponsor:   Postgraduate Institute of Medical Education and Research Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 23, 2022 Category: Research Source Type: clinical trials

Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Cataract Surgery
Conditions:   Corneal Edema;   Corneal Defect;   Anterior Chamber Inflammation;   Ocular Pain;   Corneal Staining;   Visual Outcome;   CME - Cystoid Macular Edema Interventions:   Drug: Dextenza 0.4Mg Ophthalmic Insert;   Drug: Prednisolone Phosphate 1%/Moxifloxacin 0.5%/Bromfenac 0.075% compound Sponsor:   Nicole Fram M.D. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 23, 2022 Category: Research Source Type: clinical trials

An RCT of Mycophenolate Mofetil (MMF) in Fibrotic Hypersensitivity Pneumonitis
Condition:   Hypersensitivity Pneumonitis Interventions:   Drug: Mycophenolate Mofetil plus prednisolone;   Drug: Prednisolone Sponsor:   Postgraduate Institute of Medical Education and Research Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 23, 2022 Category: Research Source Type: clinical trials

Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Cataract Surgery
Conditions:   Corneal Edema;   Corneal Defect;   Anterior Chamber Inflammation;   Ocular Pain;   Corneal Staining;   Visual Outcome;   CME - Cystoid Macular Edema Interventions:   Drug: Dextenza 0.4Mg Ophthalmic Insert;   Drug: Prednisolone Phosphate 1%/Moxifloxacin 0.5%/Bromfenac 0.075% compound Sponsor:   Nicole Fram M.D. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 23, 2022 Category: Research Source Type: clinical trials

An RCT of Mycophenolate Mofetil (MMF) in Fibrotic Hypersensitivity Pneumonitis
Condition:   Hypersensitivity Pneumonitis Interventions:   Drug: Mycophenolate Mofetil plus prednisolone;   Drug: Prednisolone Sponsor:   Postgraduate Institute of Medical Education and Research Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 23, 2022 Category: Research Source Type: clinical trials

Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Cataract Surgery
Conditions:   Corneal Edema;   Corneal Defect;   Anterior Chamber Inflammation;   Ocular Pain;   Corneal Staining;   Visual Outcome;   CME - Cystoid Macular Edema Interventions:   Drug: Dextenza 0.4Mg Ophthalmic Insert;   Drug: Prednisolone Phosphate 1%/Moxifloxacin 0.5%/Bromfenac 0.075% compound Sponsor:   Nicole Fram M.D. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 23, 2022 Category: Research Source Type: clinical trials

An RCT of Mycophenolate Mofetil (MMF) in Fibrotic Hypersensitivity Pneumonitis
Condition:   Hypersensitivity Pneumonitis Interventions:   Drug: Mycophenolate Mofetil plus prednisolone;   Drug: Prednisolone Sponsor:   Postgraduate Institute of Medical Education and Research Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 23, 2022 Category: Research Source Type: clinical trials

Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Cataract Surgery
Conditions:   Corneal Edema;   Corneal Defect;   Anterior Chamber Inflammation;   Ocular Pain;   Corneal Staining;   Visual Outcome;   CME - Cystoid Macular Edema Interventions:   Drug: Dextenza 0.4Mg Ophthalmic Insert;   Drug: Prednisolone Phosphate 1%/Moxifloxacin 0.5%/Bromfenac 0.075% compound Sponsor:   Nicole Fram M.D. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 23, 2022 Category: Research Source Type: clinical trials

An RCT of Mycophenolate Mofetil (MMF) in Fibrotic Hypersensitivity Pneumonitis
Condition:   Hypersensitivity Pneumonitis Interventions:   Drug: Mycophenolate Mofetil plus prednisolone;   Drug: Prednisolone Sponsor:   Postgraduate Institute of Medical Education and Research Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 23, 2022 Category: Research Source Type: clinical trials

Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Cataract Surgery
Conditions:   Corneal Edema;   Corneal Defect;   Anterior Chamber Inflammation;   Ocular Pain;   Corneal Staining;   Visual Outcome;   CME - Cystoid Macular Edema Interventions:   Drug: Dextenza 0.4Mg Ophthalmic Insert;   Drug: Prednisolone Phosphate 1%/Moxifloxacin 0.5%/Bromfenac 0.075% compound Sponsor:   Nicole Fram M.D. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 23, 2022 Category: Research Source Type: clinical trials

An RCT of Mycophenolate Mofetil (MMF) in Fibrotic Hypersensitivity Pneumonitis
Condition:   Hypersensitivity Pneumonitis Interventions:   Drug: Mycophenolate Mofetil plus prednisolone;   Drug: Prednisolone Sponsor:   Postgraduate Institute of Medical Education and Research Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 23, 2022 Category: Research Source Type: clinical trials

Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Cataract Surgery
Conditions:   Corneal Edema;   Corneal Defect;   Anterior Chamber Inflammation;   Ocular Pain;   Corneal Staining;   Visual Outcome;   CME - Cystoid Macular Edema Interventions:   Drug: Dextenza 0.4Mg Ophthalmic Insert;   Drug: Prednisolone Phosphate 1%/Moxifloxacin 0.5%/Bromfenac 0.075% compound Sponsor:   Nicole Fram M.D. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 23, 2022 Category: Research Source Type: clinical trials